rhodiola and estrogen positive breast cancer

Release time ：Dec-28,2024

Rhodiola, recognized as an adaptogenic herb, is frequently utilized to boost physical strength and stamina, as well as to counteract fatigue. However, for individuals with estrogen receptor-positive breast cancer, there may be associated risks with its consumption. The progression of this form of breast cancer is intricately linked to estrogen levels within the body, and Rhodiola is hypothesized to potentially influence estrogen metabolism and function.

Primarily, Rhodiola might modulate the hypothalamic-pituitary-adrenal (HPA) axis, which could indirectly alter estrogen levels by affecting the body's stress response. Moreover, certain research suggests that Rhodiola possesses estrogenic-like properties, implying that it might interact with estrogen receptors, thereby potentially fostering the proliferation of breast cancer cells. Furthermore, albeit infrequent, there are documented cases indicating that Rhodiola could precipitate hormonal imbalances, a matter of significant concern for those with estrogen receptor-positive breast cancer.

Consequently, it is advisable for patients with estrogen receptor-positive breast cancer to seek medical counsel prior to incorporating Rhodiola into their regimen. Doctors may evaluate the risks and benefits associated with Rhodiola use, taking into account the patient's unique situation, including the specific breast cancer subtype, treatment protocols, and personal health profile. Patients are encouraged to adhere to their physician's advice and exercise caution with any supplements that could influence estrogen levels.